Assessing the Potential Health Impact of Omicron (News)
https://www.swisstph.ch/en/news/assessing-the-potential-health-impact-of-omicron
The infectivity, severity, and immune evasion properties of Omicron will influence how dominant the variant becomes and what the disease burden will be. Swiss TPH modelers looked at a wide range of th
Julia Bohlius Is Awarded the Dora Seif Prize (News)
https://www.swisstph.ch/en/news/news-detail/news/julia-bohlius-is-awarded-the-dora-seif-prize
Every two years, the Basel-based Dora Seif Foundation awards the Dora Seif Cancer Research Prize, worth CHF 5000, for the best work that contributes to improving the early diagnosis and therapy (preve
Mathematical Modelling to Inform Next-Generation Malaria Interventions (News)
https://www.swisstph.ch/en/news/news-detail/news/mathematical-modelling-to-inform-next-generation-malaria-interventions
With increasing threats of malaria drug and insecticide resistance, there is now a need for novel malaria interventions to improve public health. According to the study published in Communications Med
Limited Trust in Health Systems Hinders Universal Health Coverage (News)
https://www.swisstph.ch/en/news/news-detail/news/limited-trust-in-health-systems-can-hinder-universal-health-coverage
Many health systems globally are currently underperforming in terms of health outcomes, the quality of health services provided, and user experience. This leads to approximately five million deaths an
Milestone in the Fight Against Sleeping Sickness (News)
https://www.swisstph.ch/en/news/news-detail/news/milestone-in-the-fight-against-sleeping-sickness
Sanofi, DNDi and the HAT-r-ACC consortium announce the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of Fexinidazole
EMA Recommends Arpraziquantel for Treatment of Schistosomiasis in Preschool-Aged Children (News)
https://www.swisstph.ch/en/news/news-detail/news/ema-recommends-arpraziquantel-for-treatment-of-schistosomiasis-in-preschool-aged-children
Today, the Pediatric Praziquantel Consortium announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive scientific opinion for a
Swiss TPH Scientist Awarded Competitive European Research Grant (News)
https://www.swisstph.ch/en/news/news-detail/news/swiss-tph-scientist-awarded-competitive-european-research-grant
Airborne pollen allergies are increasing across Europe due to climate change. Marloes Eeftens' research looks at the effect of pollen exposure on mortality, hospitalisation and allergic symptoms. The
High-Tech Sensors and Blockchain: New Avenues Towards Elimination of Rabies (News)
https://www.swisstph.ch/en/news/news-detail/news/high-tech-sensors-and-blockchain-new-avenues-towards-elimination-of-rabies
Rabies is an infectious viral disease that is nearly always fatal once the virus has reached the brain of the infected person. Rabies is a zoonotic disease, meaning that the virus is transmitted from
Swiss TPH and PNGIMR: Strengthening a 30-Year Partnership (News)
https://www.swisstph.ch/en/news/news-detail/news/swiss-tph-and-pngimr-strengthening-a-30-year-partnership
Swiss TPH and the Papua New Guinea Institute of Medical Research (PNGIMR) have a long and successful history of collaboration, primarily in the field of malaria, with a strong emphasis on capacity bui
Claudia Schmutz erhält Fakultätspreis der Uni Basel (News)
https://www.swisstph.ch/en/news/news-detail/news/claudia-schmutz-erhaelt-fakultaetspreis-der-uni-basel
Seit dem ersten Epidemiengesetz von 1886, werden Infektionskrankheiten in der Schweiz mit dem obligatorischen Meldesystem des Bundes überwacht. "Claudia Schmutz' Dissertation analysiert am Beispiel vo